Nanostructured transdermal hormone replacement therapy for relieving menopausal symptoms: a confocal Raman spectroscopy study

OBJECTIVE: To determine the safety and efficacy of a transdermal nanostructured formulation of progesterone (10%) combined with estriol (0.1%) + estradiol (0.25%) for relieving postmenopausal symptoms. METHODS: A total of 66 postmenopausal Brazilian women with climacteric symptoms of natural menopau...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Botelho, Marco Antonio, Queiroz, Dinalva Brito, Barros, Gisele, Guerreiro, Stela, Fechine, Pierre, Umbelino, Sonia, Lyra, Arão, Borges, Boniek, Freitas, Allan, de Queiroz, Danilo Caldas, Ruela, Ronaldo, Almeida, Jackson Guedes, Quintans, Lucindo
Format: Artigo
Langue:Inglês
Publié: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2014
Sujets:
Clinical Science
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3912337/
https://ncbi.nlm.nih.gov/pubmed/24519196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6061/clinics/2014(02)01
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires